Showing results (171-180 of 314) with videos related to
Sort By:
Pageof 32
Acta Pharmacologica Sinica|June 16, 2015
High yield and efficient expression and purification of the human 5-HT3A receptorZhong-shan Wu, Zhi-cheng Cui, Hao Cheng, et al.Nature Communications|March 7, 2023
Structural basis of peptide recognition and activation of endothelin receptorsYujie Ji, Jia Duan, Qingning Yuan, et al.Science (New York, N.Y.)|March 26, 2011
FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesisSerkan Kir, Sara A Beddow, Varman T Samuel, et al.Plant Signaling & Behavior|April 21, 2012
Catalytic mechanism and kinase interactions of ABA-signaling PP2C phosphatasesX Edward Zhou, Fen-Fen Soon, Ley-Moy Ng, et al.Cell Research|November 22, 2014
Structural basis of AMPK regulation by adenine nucleotides and glycogenXiaodan Li, Lili Wang, X Edward Zhou, et al.Nature|July 31, 2023
Conserved class B GPCR activation by a biased intracellular agonistLi-Hua Zhao, Qian He, Qingning Yuan, et al.Acta Pharmacologica Sinica|February 4, 2026
Molecular basis for cross-activation of NPFF2R by a short PrRP-related peptideXin Li, Shuai Li, Hong Shan, et al.Structure (London, England : 1993)|May 23, 2017
Structural Basis of TPR-Mediated Oligomerization and Activation of Oncogenic Fusion KinasesKuntal Pal, Abhishek Bandyopadhyay, X Edward Zhou, et al.Acta Pharmaceutica Sinica. B|October 24, 2025
Divergent activation patterns of BRS3 revealed by two Chinese herb-derived agonistsJie Li, Changyao Li, Qingtong Zhou, et al.Cancer Research|August 23, 2014
SAR405838: an optimized inhibitor of MDM2-p53 interaction that induces complete and durable tumor regressionShaomeng Wang, Wei Sun, Yujun Zhao, et al.Pageof 32